Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · Real-Time Price · USD
0.755
+0.115 (18.02%)
Nov 5, 2024, 3:49 PM EST - Market open
Athira Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Nov '24 Nov 5, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Market Capitalization | 29 | 92 | 120 | 487 | 1,113 | - | |
Market Cap Growth | -9.27% | -22.89% | -75.36% | -56.26% | - | - | |
Enterprise Value | -66 | -79 | -99 | 253 | 887 | - | |
Last Close Price | 0.64 | 2.43 | 3.17 | 13.03 | 34.25 | - | |
PE Ratio | - | -0.79 | -1.25 | -8.77 | -20.54 | - | |
PB Ratio | 0.30 | 0.71 | 0.51 | 1.52 | 4.06 | - | |
P/FCF Ratio | -1.03 | -0.92 | -1.63 | -10.89 | -42.09 | - | |
P/OCF Ratio | -1.03 | -0.92 | -1.65 | -11.29 | -46.14 | - | |
EV/EBITDA Ratio | 0.16 | 0.62 | 1.06 | -3.98 | -44.38 | - | |
EV/EBIT Ratio | 0.16 | 0.62 | 1.05 | -3.95 | -44.38 | - | |
EV/FCF Ratio | 0.19 | 0.78 | 1.35 | -5.66 | -33.57 | - | |
Debt / Equity Ratio | 0.02 | 0.01 | 0.01 | 0.01 | 0.00 | -0.58 | |
Debt / FCF Ratio | -0.01 | -0.02 | -0.03 | -0.04 | -0.04 | -0.42 | |
Quick Ratio | 3.47 | 5.17 | 9.41 | 27.56 | 42.22 | 1.62 | |
Current Ratio | 3.97 | 5.37 | 9.68 | 28.07 | 43.66 | 1.70 | |
Return on Equity (ROE) | -84.57% | -64.42% | -34.39% | -18.43% | -14.69% | - | |
Return on Assets (ROA) | -47.53% | -37.97% | -19.91% | -13.09% | -8.87% | -95.64% | |
Return on Capital (ROIC) | -55.90% | -43.07% | -20.98% | -13.38% | -9.12% | -385.47% | |
Earnings Yield | -461.23% | -127.25% | -79.75% | -11.27% | -1.79% | - | |
FCF Yield | -400.34% | -109.28% | -61.38% | -9.18% | -2.38% | - | |
Buyback Yield / Dilution | -0.83% | -0.76% | -2.20% | -208.53% | -235.50% | -2.82% | |
Total Shareholder Return | -0.83% | -0.76% | -2.20% | -208.53% | -235.50% | -2.82% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.